Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Raoul Pal: Cryptocurrency market capitalization will surpass $100 trillion between 2032 and 2034

Raoul Pal: Cryptocurrency market capitalization will surpass $100 trillion between 2032 and 2034

AiCoinAiCoin2026/07/17 06:26
Show original
Real Vision founder Raoul Pal stated that, based on the logarithmic regression curve of market adoption over the past decade, the total cryptocurrency market capitalization is expected to surpass $100 trillion between 2032 and 2034. Currently, the total global asset value is around $800 trillion, gold market capitalization is approximately $30 trillion, the global M2 money supply is roughly $80 trillion, and the digital asset market capitalization is close to $3.5 trillion. If this prediction comes true, nearly $97 trillion worth of wealth will be added within ten years, exceeding the combined fortunes of all Russian and US tech and financial real estate billionaires. Raoul Pal pointed out that cryptocurrency is one of the few assets capable of outperforming fiat currency depreciation and is a core asset in the era of exponential growth.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.

Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.

智通财经•2026/09/29 03:11

Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request

A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.

智通财经•2026/09/29 02:46